These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6719598

  • 1. [Individual variations in the oxidative metabolism of drugs. Significance of monogenic polymorphism].
    Brøsen K.
    Ugeskr Laeger; 1984 Mar 26; 146(13):955-9. PubMed ID: 6719598
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Methods for studying the hepatic metabolism of drugs in man].
    Geneve J, Bergmann JF, Caulin C, Segrestaa JM.
    Therapie; 1990 Mar 26; 45(2):91-7. PubMed ID: 2191470
    [Abstract] [Full Text] [Related]

  • 4. The genetic control of drug oxidation in the liver.
    Dayer P, Balant L, Fabre J.
    Int J Clin Pharmacol Res; 1983 Mar 26; 3(6):421-5. PubMed ID: 6147316
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases].
    Niewiński P, Orzechowska-Juzwenko K.
    Pol Merkur Lekarski; 1997 Jan 26; 2(7):71-5. PubMed ID: 9296908
    [No Abstract] [Full Text] [Related]

  • 9. [Genetic polymorphism of drug oxidation].
    Heller FR, Leclercq V, Harvengt C.
    Acta Gastroenterol Belg; 1988 Jan 26; 51(1):91-101. PubMed ID: 3055790
    [No Abstract] [Full Text] [Related]

  • 10. [The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases].
    Niewiński P, Orzechowska-Juzwenko K.
    Postepy Hig Med Dosw; 1996 Jan 26; 50(4):321-32. PubMed ID: 9019742
    [Abstract] [Full Text] [Related]

  • 11. [Clinical consequences of acetylation polymorphism].
    Jendryczko A, Gmiński J.
    Pol Tyg Lek; 1984 Sep 10; 39(37):1249-52. PubMed ID: 6150471
    [No Abstract] [Full Text] [Related]

  • 12. [Catabolism of drugs through oxidation].
    Staudinger H, Degkwitz E, Ullrich V.
    Med Welt; 1969 Dec 20; 51():2747-54. PubMed ID: 5371539
    [No Abstract] [Full Text] [Related]

  • 13. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.
    Touw DJ.
    Drug Metabol Drug Interact; 1997 Dec 20; 14(2):55-82. PubMed ID: 9893738
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.
    Idle JR, Smith RL.
    Drug Metab Rev; 1979 Dec 20; 9(2):301-17. PubMed ID: 158499
    [No Abstract] [Full Text] [Related]

  • 15. [Liver- and drug metabolism].
    Schmid E, Ritter U.
    Dtsch Med J; 1971 Nov 20; 22(22):695-7. PubMed ID: 5134616
    [No Abstract] [Full Text] [Related]

  • 16. [Morphological biochemical species differences in toxicological studies].
    Lehmann H, Busch U.
    Acta Histochem Suppl; 1985 Nov 20; 31():19-22. PubMed ID: 3927399
    [No Abstract] [Full Text] [Related]

  • 17. Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings].
    Idle JR, Sloan TP, Smith RL, Wakile LA.
    Br J Pharmacol; 1979 Jul 20; 66(3):430P-431P. PubMed ID: 526719
    [No Abstract] [Full Text] [Related]

  • 18. [Metabolism of drugs. I. Basic metabolic reactions].
    Dyderski S, Grzymisławski M.
    Pol Merkur Lekarski; 2005 Apr 20; 18(106):446-52. PubMed ID: 16161932
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The biochemistry of drug metabolism--an introduction: part 6. Inter-individual factors affecting drug metabolism.
    Krämer SD, Testa B.
    Chem Biodivers; 2008 Dec 20; 5(12):2465-578. PubMed ID: 19089818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.